Other Assets	6 Months Ended
Jun. 30, 2012
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
OTHER ASSETS	OTHER ASSETS Included in other assets are net capitalized software development costs of $50,884 and $51,117 as of June 30, 2012 and December 31, 2011, respectively. Amortization expense on capitalized software of $4,231 and $4,832 was included in product cost of sales for the three months ended June 30, 2012 and 2011, respectively, and $8,601 and $9,408 for the six months ended June 30, 2012 and 2011, respectively. Other long-term assets also consist of patents, trademarks and other intangible assets. Where applicable, other assets are stated at cost and, if applicable, are amortized ratably over the relevant contract period or the estimated life of the assets. Fees to renew or extend the term of the Company’s intangible assets are expensed when incurred. Impairment of long-lived assets is recognized when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If the expected future undiscounted cash flows are less than the carrying amount of the asset group, an impairment loss may be recognized at that time to reduce the asset to the lower of its fair value or its net book value. The Company recorded $2,962 of software intangible asset impairment charges within Diebold North America (DNA) continuing operations in the second quarter of 2011. Investment in Affiliate Investment in the Company’s non-consolidated affiliate is accounted for under the equity method and consists of a 50 percent ownership in Shanghai Diebold King Safe Company, Ltd. The balance of this investment as of June 30, 2012 and December 31, 2011 was $12,053 and $11,461, respectively, and fluctuated based on equity earnings and dividends. Equity earnings from the non-consolidated affiliate are included in miscellaneous, net in the condensed consolidated statements of income and were $345 and $434 for the three months ended June 30, 2012 and 2011, respectively, and $592 and $859 for the six months ended June 30, 2012 and 2011, respectively.

OTHER ASSETS

Included in other assets are net capitalized software development costs of $50,884 and $51,117 as of June 30, 2012 and December 31, 2011, respectively. Amortization expense on capitalized software of $4,231 and $4,832 was included in product cost of sales for the three months ended June 30, 2012 and 2011, respectively, and $8,601 and $9,408 for the six months ended June 30, 2012 and 2011, respectively. Other long-term assets also consist of patents, trademarks and other intangible assets. Where applicable, other assets are stated at cost and, if applicable, are amortized ratably over the relevant contract period or the estimated life of the assets. Fees to renew or extend the term of the Company’s intangible assets are expensed when incurred. Impairment of long-lived assets is recognized when events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If the expected future undiscounted cash flows are less than the carrying amount of the asset group, an impairment loss may be recognized at that time to reduce the asset to the lower of its fair value or its net book value. The Company recorded $2,962 of software intangible asset impairment charges within Diebold North America (DNA) continuing operations in the second quarter of 2011.

Investment in Affiliate Investment in the Company’s non-consolidated affiliate is accounted for under the equity method and consists of a 50 percent ownership in Shanghai Diebold King Safe Company, Ltd. The balance of this investment as of June 30, 2012 and December 31, 2011 was $12,053 and $11,461, respectively, and fluctuated based on equity earnings and dividends. Equity earnings from the non-consolidated affiliate are included in miscellaneous, net in the condensed consolidated statements of income and were $345 and $434 for the three months ended June 30, 2012 and 2011, respectively, and $592 and $859 for the six months ended June 30, 2012 and 2011, respectively.